Billets de Michelle Dawson

Billet publié sur Twitter/X le 19/11/2020 01:25

Twitter/X Essai clinique clinicaltrials.gov Question posée par Dawson dans le billet Lien intégré au billet Termes sur l’autisme

Liens cités structurés

1 ressource citée

Essai clinique Récupéré Publication clinicaltrials.gov

Holland Bloorview Kids Rehabilitation Hospital, United States Department of Defense (2013). Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism Spectrum Disorders (ASD). ClinicalTrials.gov. Holland Bloorview Kids Rehabilitation Hospital.

Date de publication
2013
Identifiant
NCT01908205
Auteurs
Holland Bloorview Kids Rehabilitation Hospital, United States Department of Defense
Source
ClinicalTrials.gov
Type de référence
clinical_trial
Éditeur
Holland Bloorview Kids Rehabilitation Hospital
Source de métadonnées
clinicaltrials.gov

Résumé

We are studying an investigational drug called intranasal oxytocin (Syntocinon®). Syntocinon® has been approved by the U.S. Food and Drug Administration for use in helping women breastfeed, but it has not been approved for use in children with ASD. However, there is previous research conducted that has indicated that after administration of oxytocin, adults with ASD demonstrated improvements in social cognition, and reduced repetitive behaviours and anxiety. There is also early research to suggest that children may also benefit in these areas. The purpose of this study is to test if oxytocin works to help children and adolescents with ASD.